Lyka Labs has entered into out-licensing / technology transfer deal with a US based Generics Company. It has entered an out-licensing / technology transfer deal for a basket of 12 Sterile Injectable Formulations for Manufacturing, Sales & Distribution in the United State of America.
The market size of the licensed formulations is approximately $ 1.4 billion, as per IMS MAT March 2017. The company will be eligible for a royalty on end sales. Going forward, the company will continue to explore opportunities to monetize its R&D capabilities in the regulated markets throughout-licensing partnerships.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.